Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer

Inclusion Criteria: * Patients with operable breast cancer * Life expectancy of at least 3 months * Adequate organ function * No allergy to Vitamin E and TRF * Provides consent to participate in trial and adhere to the study protocol Exclusion Criteria: * Receiving concomitant chemotherapy, radiotherapy, hormonal, immune therapy or other investigational drugs * Uncontrolled concurrent illness * Pregnant / breast feeding women * Patients who are unable or unwilling to take Tocotrienols, herbal remedies, or non-prescription medications